{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:48:47Z","timestamp":1770986927812,"version":"3.50.1"},"reference-count":111,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acute lymphoblastic leukaemia (ALL) is a relevant form of childhood neoplasm, as it accounts for over 80% of all leukaemia cases. T-cell ALL constitutes a genetically heterogeneous cancer derived from T-lymphoid progenitors. The diagnosis of T-ALL is based on morphologic, immunophenotypic, cytogenetic, and molecular features, thus the results are used for patient stratification. Due to the expression of surface and intracellular antigens, several subtypes of T-ALL can be distinguished. Although the aetiology of T-ALL remains unclear, a wide spectrum of rearrangements and mutations affecting crucial signalling pathways has been described so far. Due to intensive chemotherapy regimens and supportive care, overall cure rates of more than 80% in paediatric T-ALL patients have been accomplished. However, improved knowledge of the mechanisms of relapse, drug resistance, and determination of risk factors are crucial for patients in the high-risk group. Even though some residual disease studies have allowed the optimization of therapy, the identification of novel diagnostic and prognostic markers is required to individualize therapy. The following review summarizes our current knowledge about genetic abnormalities in paediatric patients with T-ALL. As molecular biology techniques provide insights into the biology of cancer, our study focuses on new potential therapeutic targets and predictive factors which may improve the outcome of young patients with T-ALL.<\/jats:p>","DOI":"10.3390\/ijms22020808","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T12:44:05Z","timestamp":1610714645000},"page":"808","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia"],"prefix":"10.3390","volume":"22","author":[{"given":"Anna","family":"Mroczek","sequence":"first","affiliation":[{"name":"Department of Paediatric Haematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Zawitkowska","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3080-0845","authenticated-orcid":false,"given":"Jerzy","family":"Kowalczyk","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-0775","authenticated-orcid":false,"given":"Monika","family":"Lejman","sequence":"additional","affiliation":[{"name":"Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Follini, E., Marchesini, M., and Roti, G. (2019). Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123021"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","article-title":"T-cell acute lymphoblastic leukemia","volume":"2016","author":"Raetz","year":"2016","journal-title":"Hematology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.leukres.2013.06.010","article-title":"Early T-cell precursor leukemia\/lymphoma in adults and children","volume":"37","author":"Allen","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11899-018-0455-9","article-title":"Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia","volume":"13","author":"Hefazi","year":"2018","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e2014073","DOI":"10.4084\/mjhid.2014.073","article-title":"Diagnosis and Subclassification of Acute Lymphoblastic Leukemia","volume":"6","author":"Chiaretti","year":"2014","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1521-6926(03)00086-0","article-title":"Classification systems for acute and chronic leukemias","volume":"16","year":"2003","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/gcc.22858","article-title":"Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children\u2019s Cancer Study Group ( TCCSG ) study L04-16","volume":"59","author":"Ohki","year":"2020","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic Basis of Acute Lymphoblastic Leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PDM.0b013e3182595516","article-title":"Multiplex Ligation-dependent Probe Amplification (MLPA) in Tumor Diagnostics and Prognostics","volume":"21","author":"Savola","year":"2012","journal-title":"Diagn. Mol. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1038\/bcj.2017.3","article-title":"Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia","volume":"7","author":"Kunz","year":"2017","journal-title":"Blood Cancer J."},{"key":"ref_12","first-page":"43","article-title":"Prognostic and therapeutic implications of genetic aberrationsin childhood acute lymphoblastic leukemia","volume":"2","author":"Pastorczak","year":"2011","journal-title":"Hematologia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1080\/10428194.2017.1312383","article-title":"MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy","volume":"58","author":"Pisecker","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jjco\/hyaa025","article-title":"Simultaneous changes in expression levels of BAALC and miR-326: A novel prognostic biomarker for childhood ALL","volume":"50","author":"Ghodousi","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_15","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.blre.2018.04.003","article-title":"T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers","volume":"32","author":"Drobna","year":"2018","journal-title":"Blood Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0352-x","article-title":"CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia","volume":"51","author":"Jang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2011.08957.x","article-title":"T-cell acute lymphoblastic leukaemia: Recent molecular biology findings","volume":"156","author":"Kraszewska","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kawashima-Goto, S., Imamura, T., Tomoyasu, C., Yano, M., Yoshida, H., Fujiki, A., Tamura, S., Osone, S., Ishida, H., and Morimoto, A. (2015). BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132926"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12288-013-0329-1","article-title":"Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief Report","volume":"30","author":"Iqbal","year":"2014","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/08998280.2018.1479579","article-title":"Early T-cell precursor acute lymphoblastic leukemia with KRAS and DNMT3A mutations and unexpected monosomy 7","volume":"31","author":"Tran","year":"2018","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_22","first-page":"10","article-title":"Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors","volume":"99","author":"Zuurbier","year":"2013","journal-title":"Haematologica"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fonc.2019.00316","article-title":"The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia","volume":"9","author":"Noronha","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: A high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.leukres.2019.01.003","article-title":"Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics","volume":"78","author":"Kumar","year":"2019","journal-title":"Leuk. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-4608(83)90086-9","article-title":"A possible subgroup of ALL with 9p\u2212","volume":"9","author":"Kowalczyk","year":"1983","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.leukres.2013.04.005","article-title":"Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia","volume":"37","author":"Lettieri","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cam4.1917","article-title":"An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression","volume":"8","author":"Haider","year":"2019","journal-title":"Cancer Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/bloodadvances.2018028993","article-title":"Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia","volume":"3","author":"Alcantara","year":"2019","journal-title":"Blood Adv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3324\/haematol.2008.004150","article-title":"T-cell acute lymphoblastic leukemia","volume":"94","author":"Chiaretti","year":"2009","journal-title":"Haematologica"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bongiovanni, D., Saccomani, V., and Piovan, E. (2017). Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18091904"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.leu.2402892","article-title":"Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: A study from the Children\u2019s Cancer Group (CCG)","volume":"17","author":"Kees","year":"2003","journal-title":"Leukemia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.arcmed.2016.11.014","article-title":"Early-age Acute Leukemia: Revisiting Two Decades of the Brazilian Collaborative Study Group","volume":"47","author":"Andrade","year":"2016","journal-title":"Arch. Med. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/gcc.22666","article-title":"KMT2A (MLL) rearrangements observed in pediatric\/young adult T-lymphoblastic leukemia\/lymphoma: A 10-year review from a single cytogenetic laboratory","volume":"57","author":"Peterson","year":"2018","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.leukres.2009.06.026","article-title":"T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements","volume":"34","author":"Mansur","year":"2010","journal-title":"Leuk. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/leu.2016.60","article-title":"MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A Children\u2019s Oncology Group Study","volume":"30","author":"Kang","year":"2016","journal-title":"Leukemia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.canlet.2019.11.005","article-title":"KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease","volume":"469","author":"Forgione","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40364-018-0141-z","article-title":"Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL","volume":"6","author":"Kang","year":"2018","journal-title":"Biomark. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3389\/fonc.2020.01184","article-title":"Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia","volume":"10","author":"Lejman","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3389\/fonc.2019.00871","article-title":"Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification","volume":"9","author":"Thakral","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2014-06-578856","article-title":"Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations","volume":"124","author":"Borga","year":"2014","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.humpath.2017.05.009","article-title":"T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation","volume":"65","author":"Dorfman","year":"2017","journal-title":"Hum. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2020.00273","article-title":"The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects","volume":"10","author":"Fattizzo","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcmd.2012.09.001","article-title":"BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients","volume":"50","author":"Kraszewska","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1182\/blood-2010-11-318873","article-title":"The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia","volume":"118","author":"Gutierrez","year":"2011","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/gcc.22664","article-title":"Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases","volume":"57","author":"Olsson","year":"2018","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.leu.2400798","article-title":"ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia","volume":"11","author":"Cacheux","year":"1997","journal-title":"Leukemia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri2476","article-title":"GATA3 and the T-cell lineage: Essential functions before and after T-helper-2-cell differentiation","volume":"9","author":"Ho","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-016-0324-8","article-title":"Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL","volume":"9","author":"Fransecky","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhang, H., Liu, A.P.Y., Devidas, M., Lee, S.H.R., Cao, X., Pei, D., Borowitz, M., Wood, B., Gastier-Foster, J.M., and Dai, Y. (2020). Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia. J. Natl. Cancer Inst.","DOI":"10.1093\/jnci\/djaa138"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1101\/gad.8.22.2691","article-title":"Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice","volume":"8","author":"Okamura","year":"1994","journal-title":"Genes Dev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1182\/blood-2009-07-234377","article-title":"Inactivation of LEF1 in T-cell acute lymphoblastic leukemia","volume":"115","author":"Gutierrez","year":"2010","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Monta\u00f1o, A., Forero-Castro, M., Marchena-Mendoza, D., Benito, R., and Hern\u00e1ndez-Rivas, J.M. (2018). New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update. Cancers, 10.","DOI":"10.3390\/cancers10040110"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e27496","DOI":"10.1002\/pbc.27496","article-title":"Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan","volume":"66","author":"Yeh","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood-2008-12-192039","article-title":"WT1 mutations in T-ALL","volume":"114","author":"Tosello","year":"2009","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00639.x","article-title":"Neurofibromin: A general outlook","volume":"70","author":"Tajara","year":"2006","journal-title":"Clin. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1101\/gr.5306606","article-title":"Suz12 binds to silenced regions of the genome in a cell-type-specific manner","volume":"16","author":"Squazzo","year":"2006","journal-title":"Genome Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/leu.2017.25","article-title":"Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia","volume":"31","author":"Yoshida","year":"2017","journal-title":"Leukemia"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1038\/s41375-019-0474-0","article-title":"Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity","volume":"33","author":"Ding","year":"2019","journal-title":"Leukemia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1182\/blood.V120.21.4622.4622","article-title":"Genetic Events in Ikaros Gene Family (IKZF1 and IKZF2) in Pediatric T-Cell Lymphoblastic Leukemia\/Lymphoma","volume":"120","author":"Narita","year":"2012","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.3892\/ol.2017.6599","article-title":"Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia","volume":"14","author":"Krzanowski","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.leu.2402000","article-title":"Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay","volume":"15","author":"Chen","year":"2001","journal-title":"Leukemia"},{"key":"ref_66","first-page":"170","article-title":"A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia","volume":"43","author":"Wang","year":"2005","journal-title":"Zhonghua Er Ke Za Zhi = Chin. J. Pediatr."},{"key":"ref_67","first-page":"127","article-title":"Does TAL-1 deletion contribute to the high incidence of T-cell acute lymphoblastic leukemia in South Indian patients?","volume":"9","author":"Sudhakar","year":"2008","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"66360","DOI":"10.18632\/oncotarget.18576","article-title":"Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cas.13859","article-title":"NOTCH 1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia","volume":"110","author":"Kimura","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/toxsci\/kfh254","article-title":"Modulation of Notch Processing by \u03b3-Secretase Inhibitors Causes Intestinal Goblet Cell Metaplasia and Induction of Genes Known to Specify Gut Secretory Lineage Differentiation","volume":"82","author":"Milano","year":"2004","journal-title":"Toxicol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/s41388-019-0802-x","article-title":"The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to \u03b3-secretase inhibition","volume":"38","author":"Hounjet","year":"2019","journal-title":"Oncogene"},{"key":"ref_72","first-page":"E93","article-title":"PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols","volume":"94","author":"Kunz","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Martelli, A.M., Paganelli, F., Fazio, A., Bazzichetto, C., Conciatori, F., and McCubrey, J.A. (2019). The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response. Cancers, 11.","DOI":"10.3390\/cancers11050629"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e26539","DOI":"10.1002\/pbc.26539","article-title":"Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood","volume":"64","author":"Fedders","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Evangelisti, C., Chiarini, F., McCubrey, J.A., and Martelli, A.M. (2018). Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071878"},{"key":"ref_77","first-page":"1","article-title":"Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"296","DOI":"10.21037\/atm.2019.04.80","article-title":"Genetic variants and clinical significance of pediatric acute lymphoblastic leukemia","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e27001","DOI":"10.1002\/pbc.27001","article-title":"Cyclin dependent kinase inhibitor 2A\/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia","volume":"65","author":"Agarwal","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-018-0639-8","article-title":"Frequency and clinical impact of CDKN2A\/ARF\/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia","volume":"11","author":"Genesca","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000320366","article-title":"p27kip1: A New Multiple Endocrine Neoplasia Gene?","volume":"93","author":"Marinoni","year":"2011","journal-title":"Neuroendocrinology"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Hung, C.-S., Wang, S.-C., Yen, Y.-T., Lee, T.-H., Wen, W.-C., and Lin, R.-K. (2018). Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103096"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.leu.2404008","article-title":"Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias","volume":"20","author":"Clappier","year":"2005","journal-title":"Leukemia"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2017.165282","article-title":"A novel AGGF1-PDGFR\u03b2 fusion in pediatric T-cell acute lymphoblastic leukemia","volume":"103","author":"Zabriskie","year":"2018","journal-title":"Haematologica"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/leu.2017.161","article-title":"Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia","volume":"31","author":"Heilmann","year":"2017","journal-title":"Leukemia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000495687","article-title":"Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene","volume":"141","author":"Bielorai","year":"2019","journal-title":"Acta Haematol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood-2017-11-817510","article-title":"PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia","volume":"131","author":"Zhang","year":"2018","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/gcc.20743","article-title":"ABLI rearrangements in T-cell acute lymphoblastic leukemia","volume":"49","author":"Hagemeijer","year":"2010","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia","volume":"115","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/ijlh.12711","article-title":"The clinical significance of monitoring the expression of theSIL-TAL1fusion gene in T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation","volume":"39","author":"Zhao","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_91","first-page":"1508","article-title":"Correlation between expression of SIL-TAL1 fusion gene and deletion of 6q in T-cell acute lymphoblastic leukemia","volume":"22","author":"Wang","year":"2014","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_92","first-page":"681","article-title":"Clinical Characteristics and Treatment Efficacy of Children with SIL\/TAL1 Positive T-Cell Acute Lymphoblastic Leukemia","volume":"24","author":"Liu","year":"2016","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/leu.2013.149","article-title":"Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia","volume":"27","author":"Nigro","year":"2013","journal-title":"Leukemia"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.leu.2405074","article-title":"The role of CALM\u2013AF10 gene fusion in acute leukemia","volume":"22","author":"Caudell","year":"2007","journal-title":"Leukemia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia","volume":"111","author":"Tchinda","year":"2008","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/ol.2014.2263","article-title":"NUP214 fusion genes in acute leukemia (Review)","volume":"8","author":"Zhou","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Papenhausen, P., Kelly, C.A., Zhang, Z., Tepperberg, J., Burnside, R.D., and Schwartz, S. (2018). Multidisciplinary analysis of pediatric T-ALL: 9q34 gene fusions. Cancer Genet., 1\u201313.","DOI":"10.1016\/j.cancergen.2018.12.002"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1084\/jem.20180570","article-title":"PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia","volume":"215","author":"Bodaar","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00432-016-2174-8","article-title":"EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia","volume":"142","author":"Ernst","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_100","first-page":"1","article-title":"EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches","volume":"34","author":"Iannotta","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"65485","DOI":"10.18632\/oncotarget.11796","article-title":"Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations","volume":"7","author":"Spinella","year":"2016","journal-title":"Oncotarget"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Palomero","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.biopha.2018.11.083","article-title":"The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone","volume":"109","author":"Xiang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1073\/pnas.86.14.5502","article-title":"Structure of the human retinoblastoma gene","volume":"86","author":"Hong","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.3324\/haematol.2016.162198","article-title":"Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma","volume":"102","author":"Hofman","year":"2017","journal-title":"Haematologica"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.2508","article-title":"Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia","volume":"45","author":"Atak","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41375-018-0176-z","article-title":"The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL","volume":"33","author":"Kampen","year":"2018","journal-title":"Leukemia"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3324\/haematol.2015.129692","article-title":"Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation","volume":"100","author":"Kunz","year":"2015","journal-title":"Haematologica"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","article-title":"Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing","volume":"52","author":"Lee","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gcc.22416","article-title":"Pediatric T-cell acute lymphoblastic leukemia","volume":"56","author":"Karrman","year":"2017","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/leu.2017.55","article-title":"Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis","volume":"31","author":"Ratnaparkhe","year":"2017","journal-title":"Leukemia"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/2\/808\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:11:24Z","timestamp":1760159484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/2\/808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":111,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["ijms22020808"],"URL":"https:\/\/doi.org\/10.3390\/ijms22020808","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}